» Articles » PMID: 38101834

Assessment of the Global Fund-supported Procurement and Supply Chain Reforms at the Ethiopian Pharmaceuticals Supply Agency: a Mixed-methods Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Dec 15
PMID 38101834
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) partnered with the Ethiopian Pharmaceutical Supply Agency (EPSA) in 2018-2019 to reform procurement and supply chain management (PSCM) procedures within the Ethiopian healthcare system. This assessment sought to determine the impact of the reforms and document the lessons learnt.

Design: Mixed-methods study incorporating qualitative and quantitative analysis. Purposive and snowballing sampling techniques were applied for the qualitative methods, and the data collected was transcribed in full and subjected to thematic content analysis. Descriptive analysis was applied to quantitative data.

Setting: The study was based in Ethiopia and focused on the EPSA operations nationally between 2017 and 2021.

Participants: Twenty-five Ethiopian healthcare decision-makers and health workers.

Intervention: Global Fund training programme for health workers and infrastructural improvements OUTCOMES: Operational and financial measures for healthcare PSCM.

Results: The availability of antiretrovirals, tuberculosis and malaria medicines, and other related commodities, remained consistently high. Line fill rate and forecast accuracy were average. Between 2018 and 2021, procurement lead times for HIV and malaria-related orders reduced by 43.0% relative to other commodities that reported an increase. Many interview respondents recognised the important role of the Global Fund support in improving the performance of EPSA and provided specific attributions to the observed successes. However, they were also clear that more needs to be done in specific critical areas such as financing, strategic reorganisation, data and information management systems.

Conclusion: The Global Fund-supported initiatives led to improvements in the EPSA performance, despite several persistent challenges. To sustain and secure the gains achieved so far through Global Fund support and make progress, it is important that various stakeholders, including the government and the donor community, work together to support EPSA in delivering on its core mandate within the Ethiopian health system.

Citing Articles

Management of drug supply chain information based on "artificial intelligence + vendor managed inventory" in China: perspective based on a case study.

Shen J, Bu F, Ye Z, Zhang M, Ma Q, Yan J Front Pharmacol. 2024; 15:1373642.

PMID: 39081951 PMC: 11286579. DOI: 10.3389/fphar.2024.1373642.

References
1.
Misganaw A, Melaku Y, Tessema G, Deribew A, Deribe K, Abera S . National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015. Popul Health Metr. 2017; 15(1):28. PMC: 5521136. DOI: 10.1186/s12963-017-0146-0. View

2.
Agrawal P, Barton I, Bianco R, Hovig D, Sarley D, Yadav P . Moving Medicine, Moving Minds: Helping Developing Countries Overcome Barriers to Outsourcing Health Commodity Distribution to Boost Supply Chain Performance and Strengthen Health Systems. Glob Health Sci Pract. 2016; 4(3):359-65. PMC: 5042692. DOI: 10.9745/GHSP-D-16-00130. View

3.
Colson K, Dwyer-Lindgren L, Achoki T, Fullman N, Schneider M, Mulenga P . Benchmarking health system performance across districts in Zambia: a systematic analysis of levels and trends in key maternal and child health interventions from 1990 to 2010. BMC Med. 2015; 13:69. PMC: 4382853. DOI: 10.1186/s12916-015-0308-5. View

4.
. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 399(10332):1322-1335. PMC: 8987934. DOI: 10.1016/S0140-6736(21)02868-3. View

5.
Seidman G, Atun R . Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries. BMJ Glob Health. 2017; 2(2):e000243. PMC: 5435270. DOI: 10.1136/bmjgh-2016-000243. View